Bracy Fertig

Bracy Fertig currently serves as the VP of Strategy and Corporate Development at Caresyntax, where responsibilities include strategic planning and corporate development within a leading healthcare technology company focused on enhancing surgical outcomes through AI integration. Prior to this role, Bracy held the position of Vice President and Healthcare Lead at IBIS Capital, facilitating capital connections for impactful healthcare technology businesses. A background in academia includes a Research Doctorate in Biochemistry from the University of Glasgow, complemented by various research roles across prestigious institutions, including VUmc and the University of Oxford. Bracy also completed a Certificate in ESG Investing from Columbia University and possesses a strong foundation in healthcare and biochemistry, underpinned by a Bachelor's Degree in Pharmacology from the University of Glasgow and further training in accounting fundamentals.